Clinical Trials List
2023-12-15 - 2030-12-31
Phase III
Not yet recruiting5
Recruiting3
ICD-10C06.9
Malignant neoplasm of mouth, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9145.9
Malignant neoplasm of mouth, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Yu Lien 無
- Yu-Min Liao 無
- 陳珈妤 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- CHENG-HSIEN LIN 無
- 陳建志 無
- 謝合原 無
- Cheng-Lun Lai 無
- 鄭皓升 無
- ZHENG-WEI ZHOU 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 廖斌志 無
- 王駿瑋 無
- YA-FANG CHEN 無
- 陳贈成 無
- Hsiang-Fong Kao 無
- Pei-Jen Lou 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 余紹銘 無
- Hung-Ming Wang 無
- Chi-Ting Liau 無
- Cheng-Lung Hsu 無
- 湯文誠 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsung-Jang Yeh 無
- Jeng-Shiun Du 無
- 王閔宏 無
- 謝子禹 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
72 participants
-
Global
1145 participants
